We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $9.59B
1-Year Est. Return 113.36%
This Fund
S&P 500
This Quarter Est. Return
+6.12%
1 Year Est. Return
+113.36%
3 Year Est. Return
+277.48%
5 Year Est. Return
+350.78%
10 Year Est. Return
+2,290.11%
AUM
$1.93B
AUM Growth
-$220M
Cap. Flow
-$748M
Cap. Flow %
-38.76%
Top 10 Hldgs %
34.72%
Holding
143
New
28
Increased
19
Reduced
29
Closed
37

Top Buys

Rank Stock Value
1
QCOR
QUESTCOR PHARMA INC
QCOR
+$75.2M
2
HUM icon
Humana
HUM
+$40.6M
3
AUXL
AUXILIUM PHARAMCEUTICALS INC
AUXL
+$30.6M
4
DVA icon
DaVita
DVA
+$28.5M
5
INFI
Infinity Pharmaceuticals, Inc.
INFI
+$25.6M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$51.8M
2
AZN icon
AstraZeneca
AZN
+$48.2M
3
ABBV icon
AbbVie
ABBV
+$45M
4
TEVA icon
Teva Pharmaceuticals
TEVA
+$35M
5
THOR
THORATEC CORPORATION
THOR
+$33.2M

Sector Composition

Rank Sector Weight
1 Miscellaneous 49.87%
2 Healthcare 48.16%
3 Financials 1.16%
4 Technology 0.74%
5 Industrials 0.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AGN
126
CALL
DELISTED
Allergan Inc
AGN
– –
-300,000
Closed -$27.1M
2 3 4 5
6

Similar funds

OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
MSE
MUFG Securities EMEA London, United Kingdom $9.53B AUM 52.96% 1-Year Est. Return
VF
Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
A
Allianz Munich, Germany $9.48B AUM 23.58% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return

Deerfield Management's Q4 2013 Portfolio in Review

As of Q4 2013, Deerfield Management held 143 positions worth $1.93B, down 10% from $2.15B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Deerfield Management withdrew a net $748M in Q4 2013, closing 37 positions and reducing 29 holdings. Its most notable exit was Pfizer, an estimated $51.8M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 50% of assets, up from 45% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Deerfield Management opened a new position in Humana worth $42.8M.

  • Deerfield Management's largest Q4 2013 buy was Humana: 414,670 shares worth $42.8M.
  • Deerfield Management added most to QUESTCOR PHARMA INC in Q4 2013, an estimated $75.2M increase.
  • Deerfield Management's biggest Q4 2013 reduction was Teva Pharmaceuticals, cutting an estimated $35M.
  • Deerfield Management fully exited Pfizer in Q4 2013, selling an estimated $51.8M.
  • Deerfield Management's ten largest holdings make up 35% of its $1.93B portfolio in Q4 2013.
  • Deerfield Management opened 28 new positions and closed 37 in Q4 2013.
  • Deerfield Management's portfolio value fell 10% quarter-over-quarter to $1.93B.

Based on Deerfield Management's 13F filing for Q4 2013, filed 14 Feb 2014.